UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046839
Receipt number R000053439
Scientific Title Impact of a hip fracture template on perioperative complication rate in hip fracture co-management by hospitalists: a retrospective cohort study
Date of disclosure of the study information 2022/02/06
Last modified on 2022/08/08 09:02:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of a hip fracture template on perioperative complication rate in hip fracture co-management by hospitalists: a retrospective cohort study

Acronym

Impact of HFT on perioperative complication rate in hip fracture co-management by hospitalists

Scientific Title

Impact of a hip fracture template on perioperative complication rate in hip fracture co-management by hospitalists: a retrospective cohort study

Scientific Title:Acronym

Impact of HFT on perioperative complication rate in hip fracture co-management by hospitalists

Region

Japan


Condition

Condition

hip fracture

Classification by specialty

Medicine in general Orthopedics Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examined its effect on morbidity in patients with hip fractures and the factors associated with complications.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

perioperative complication rate

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients who underwent surgery for hip fracture in Akashi medical center between July 2020 and September 2021

Key exclusion criteria

patients with periprosthetic fracture

Target sample size

243


Research contact person

Name of lead principal investigator

1st name Naoto
Middle name
Last name Ishimaru

Organization

Akashi Medical Center

Division name

Department of General Internal Medicine

Zip code

6740063

Address

743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan

TEL

0789361101

Email

maru-tkb@umin.ac.jp


Public contact

Name of contact person

1st name Naoto
Middle name
Last name Ishimaru

Organization

Akashi Medical Center

Division name

Department of General Internal Medicine

Zip code

6740063

Address

743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan

TEL

0789361101

Homepage URL


Email

maru-tkb@umin.ac.jp


Sponsor or person

Institute

Akashi Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Akashi Medical Center

Address

743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan

Tel

0789361101

Email

yokoyama.naoki@aijinkai-group.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 12 Month 23 Day

Date of IRB

2022 Year 01 Month 24 Day

Anticipated trial start date

2022 Year 01 Month 27 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Demographic data, items used in the template, and comorbidities were obtained from patient's charts.


Management information

Registered date

2022 Year 02 Month 06 Day

Last modified on

2022 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053439